𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation

✍ Scribed by C. C. Quarles; B. D. Ward; K. M. Schmainda


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
638 KB
Volume
53
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A new approach to improve the reliability of dynamic susceptibility contrast MRI for the evaluation of brain tumor hemodynamics in the presence of contrast agent extravasation is described. This model‐based technique simultaneously estimates the voxel‐wise tumor residue function and the temporal extravascular T~1~ changes following contrast agent leakage. With these estimates the model corrects the measured MRI signal, which is then used to calculate tumor hemodynamic parameters. The feasibility of this technique is demonstrated with computer simulations that cover a wide range of hemodynamic conditions and by application to eight tumor‐bearing rats. The simulations demonstrate that the corrected hemodynamic parameters precisely matched the actual values with a maximum percentage error of 4.2% compared to 68.6% for the uncorrected parameters. The corrected parameters are also essentially independent of the tumor hemodynamic state and degree of contrast extravasation. Consistent with these improvements, significant differences between corrected and uncorrected parameters, calculated from a gradient‐echo sequence, are shown in a rat 9L gliosarcoma model. This method combined with the hemodynamic parameters derived from GE and SE sequences shows promise as a new tool to evaluate tumor angiogenesis and its therapy. Magn Reson Med 53:1307–1316, 2005. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Enhanced tumor detection in the presence
✍ Burkhard P. Kreft; Akihiro Tanimoto; Yuji Baba; Longhai Zhao; J. Paul Finn; Davi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

## Abstract It is assumed that hepatobiliary, cell‐specific contrast agents will be adversely affected by the presence of diffuse liver disease. The diagnostic efficacy for tumor detection in the presence of fatty liver disease was experimentally studied at contrast‐enhanced magnetic resonance (MR)